Artur Mitterer

799 total citations
35 papers, 632 citations indexed

About

Artur Mitterer is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, Artur Mitterer has authored 35 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 13 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Artur Mitterer's work include Platelet Disorders and Treatments (13 papers), Hemophilia Treatment and Research (8 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (6 papers). Artur Mitterer is often cited by papers focused on Platelet Disorders and Treatments (13 papers), Hemophilia Treatment and Research (8 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (6 papers). Artur Mitterer collaborates with scholars based in Austria, Canada and United States. Artur Mitterer's co-authors include Friedrich Dorner, Peter L. Turecek, Wolfgang Mundt, Bernhard Fischer, Michael Graninger, J. Eibl, Peter Matthiessen, Uwe Schlokat, Herbert Gritsch and N Barrett and has published in prestigious journals such as Journal of Biological Chemistry, Blood and FEBS Letters.

In The Last Decade

Artur Mitterer

33 papers receiving 568 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Artur Mitterer Austria 13 387 181 142 72 68 35 632
C Bloy France 17 558 1.4× 237 1.3× 96 0.7× 42 0.6× 157 2.3× 33 926
J. Michael Kilpatrick United States 16 112 0.3× 267 1.5× 246 1.7× 59 0.8× 36 0.5× 29 665
Frances A. Pitlick United States 11 338 0.9× 131 0.7× 67 0.5× 40 0.6× 24 0.4× 17 586
Gordon B. Ryan United Kingdom 13 432 1.1× 299 1.7× 382 2.7× 23 0.3× 51 0.8× 26 950
TA Rado United States 7 129 0.3× 225 1.2× 217 1.5× 45 0.6× 75 1.1× 11 550
J. Andrew Bristol United States 16 81 0.2× 295 1.6× 137 1.0× 26 0.4× 171 2.5× 20 626
Julia Tait Lathrop United States 12 112 0.3× 636 3.5× 91 0.6× 28 0.4× 46 0.7× 17 910
O Hallé-Pannenko France 16 161 0.4× 135 0.7× 511 3.6× 54 0.8× 45 0.7× 67 772
M Baer United States 7 142 0.4× 217 1.2× 149 1.0× 14 0.2× 52 0.8× 14 558
V. Nuessler Germany 13 124 0.3× 183 1.0× 218 1.5× 23 0.3× 51 0.8× 20 512

Countries citing papers authored by Artur Mitterer

Since Specialization
Citations

This map shows the geographic impact of Artur Mitterer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Artur Mitterer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Artur Mitterer more than expected).

Fields of papers citing papers by Artur Mitterer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Artur Mitterer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Artur Mitterer. The network helps show where Artur Mitterer may publish in the future.

Co-authorship network of co-authors of Artur Mitterer

This figure shows the co-authorship network connecting the top 25 collaborators of Artur Mitterer. A scholar is included among the top collaborators of Artur Mitterer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Artur Mitterer. Artur Mitterer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Turecek, Peter L., Srilatha Tangada, Herbert Gritsch, et al.. (2015). Nonacog gamma, a novel recombinant factor IX with low factor IXa content for treatment and prophylaxis of bleeding episodes. Expert Review of Clinical Pharmacology. 8(2). 163–177. 6 indexed citations
2.
Seyfried, Birgit, Michael Dockal, Michael Graninger, et al.. (2015). Differences in N-glycosylation of recombinant human coagulation factor VII derived from BHK, CHO, and HEK293 cells. BMC Biotechnology. 15(1). 87–87. 51 indexed citations
3.
Turecek, Peter L., J. Siekmann, Artur Mitterer, et al.. (2015). Development of BAX 826, a Polysialylated Full-Length rFVIII with Significantly Improved PK Properties. Blood. 126(23). 3536–3536. 3 indexed citations
4.
Turecek, Peter L., M.J. Bossard, Michael Graninger, et al.. (2012). BAX 855, a PEGylated rFVIII product with prolonged half-life. Development, functional and structural characterisation.. PubMed. 32 Suppl 1. S29–38. 86 indexed citations
5.
Dockal, Michael, Michael Graninger, Meinhard Hasslacher, et al.. (2011). Expression of recombinant human coagulation factors VII (rFVII) and IX (rFIX) in various cell types, glycosylation analysis, and pharmacokinetic comparison. BMC Proceedings. 5(S8). P23–P23. 4 indexed citations
6.
Gerenčer, Marijan, Peter L. Turecek, Otfried Kistner, et al.. (2006). In vitro and in vivo anti-retroviral activity of the substance purified from the aqueous extract of Chelidonium majus L.. Antiviral Research. 72(2). 153–156. 33 indexed citations
7.
Kolarich, Daniel, Peter L. Turecek, Alfred Weber, et al.. (2006). Biochemical, molecular characterization, and glycoproteomic analyses of α1‐proteinase inhibitor products used for replacement therapy*. Transfusion. 46(11). 1959–1977. 59 indexed citations
8.
Turecek, Peter L., Artur Mitterer, Herbert Gritsch, et al.. (2006). Biochemical and Functional Characterization of a Serum-Free rVWF Drug Candidate.. Blood. 108(11). 1017–1017. 2 indexed citations
9.
Schwarz, Hans Peter, Uwe Schlokat, Artur Mitterer, et al.. (2002). Recombinant von Willebrand Factor-Insight into Structure and Function through Infusion Studies in Animals with Severe von Willebrand Disease. Seminars in Thrombosis and Hemostasis. 28(2). 215–226. 12 indexed citations
10.
Plaimauer, Barbara, Uwe Schlokat, Peter L. Turecek, et al.. (2001). Recombinant von Willebrand Factor: Preclinical Development. Seminars in Thrombosis and Hemostasis. 27(4). 395–404. 16 indexed citations
11.
Gerenčer, Marijan, Perry Barrett, Otfried Kistner, Artur Mitterer, & Friedrich Dorner. (1998). Natural IgM Antibodies in Baby Rabbit Serum Bind High-Mannose Glycans on HIV Type 1 Glycoprotein 120/160 and Activate Classic Complement Pathway. AIDS Research and Human Retroviruses. 14(7). 599–605. 8 indexed citations
12.
Fischer, Bernhard, Artur Mitterer, & Friedrich Dorner. (1996). Qualitative and quantitative detection of human and recombinant thrombin by binding to leech and recombinant hirudin immobilized at the soild phase. Thrombosis Research. 81(1). 157–162. 2 indexed citations
13.
14.
Fischer, Bernhard, Artur Mitterer, Manfred Reiter, et al.. (1996). EFFECT OF MULTIMERIZATION OF HUMAN AND RECOMBINANT VON WILLEBRAND FACTOR ON PLATELET AGGREGATION, BINDING TO COLLAGEN AND BINDING OF COAGULATION FACTOR VIII. Thrombosis Research. 84(1). 55–66. 55 indexed citations
15.
Fischer, Bernhard, Uwe Schlokat, Artur Mitterer, et al.. (1996). Rational Design, Recombinant Preparation, and in Vitro and in Vivo Characterization of Human Prothrombin-derived Hirudin Antagonists. Journal of Biological Chemistry. 271(39). 23737–23742. 2 indexed citations
16.
Fischer, Bernhard, Artur Mitterer, & Friedrich Dorner. (1995). Purification of recombinant human coagulation factors II and IX and protein S expressed in recombinant Vaccinia virus-infected Vero cells. Journal of Biotechnology. 38(2). 129–136. 12 indexed citations
17.
Fischer, Bernhard, Uwe Schlokat, Artur Mitterer, et al.. (1995). Structural analysis of recombinant von Willebrand factor produced at industrial scale fermentation of transformed CHO cells co‐expressing recombinant furin. FEBS Letters. 375(3). 259–262. 22 indexed citations
18.
Fischer, Bernhard, et al.. (1994). Structural analysis of recombinant von Willebrand factor: Identification of hetero‐ and homo‐dimers. FEBS Letters. 351(3). 345–348. 18 indexed citations
19.
Falkner, Falko G., P. L. Turecek, Ross T. A. MacGillivray, et al.. (1992). High Level Expression of Active Human Prothrombin in a Vaccina Virus Expression System. Thrombosis and Haemostasis. 68(2). 119–124. 12 indexed citations
20.
Barrett, N, Artur Mitterer, Wolfgang Mundt, et al.. (1989). Large-Scale Production and Purification of a Vaccinia Recombinant-Derived HIV-1 gp160 and Analysis of Its Immunogenicity. AIDS Research and Human Retroviruses. 5(2). 159–171. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C Bloy Breakdown of academic impact, for papers by J. Michael Kilpatrick Breakdown of academic impact, for papers by Frances A. Pitlick Breakdown of academic impact, for papers by Gordon B. Ryan Breakdown of academic impact, for papers by TA Rado Breakdown of academic impact, for papers by J. Andrew Bristol Breakdown of academic impact, for papers by Julia Tait Lathrop Breakdown of academic impact, for papers by O Hallé-Pannenko Breakdown of academic impact, for papers by M Baer Breakdown of academic impact, for papers by V. Nuessler
Rankless by CCL
2026